Real-Time Adherence Monitoring for Clinical Trials
An end-to-end platform that keeps participants on protocol, surfaces actionable insights, and supports remote engagement, so trial teams decide faster.
Bring effective treatments to market faster, for less
Infectious disease trials often struggle with poor adherence and high dropout, delaying time-to-market for critical medications. SureAdhere keeps participants on protocol, surfaces actionable insights, and supports remote engagement, helping sponsors, sites, and CROs make faster, data-driven decisions about regimen efficacy.
Everything you need for high-fidelity trials.
Ensure High Adherence to Treatment
Drive high adherence with configurable dose reminders and detailed dosing histories, accelerating trials and delivering the data that confirms regimen efficacy.
- Configurable dose reminders and complex regimen support
- Detailed dosing histories and side-effect capture
- CDC-validated Video Directly Observed Therapy (VDOT)
- Works offline for participants in low-connectivity settings
Make Confident Decisions
Gain real-time adherence data to support participants, enable timely interventions, and make confident decisions about drug efficacy, all integrated into your trial database.
- Real-time adherence dashboards for sponsors, CROs, and sites
- Seamless integration with IRT, EDC, CDR, and MEMs devices
- Site-level reporting to validate implementation fidelity
- Audit-ready data logs compliant with 21 CFR Part 11
Engage & Support Participants
Support participants remotely throughout the trial, saving staff and participant time while reducing dropout, even in low-literacy or low-connectivity settings.
- Icon-driven, offline-capable mobile app
- Secure in-app messaging and live virtual visits
- Participant-facing treatment calendar and progress tracking
- Multilingual support for global trial populations
Leading in Privacy & Security
SureAdhere complies with HIPAA and GDPR, is 21 CFR Part 11 compliant, and is regularly audited by trial sponsors and CROs. Our global team backs it with service level agreements in your time zone.
Clinical trial teams who trust SureAdhere.
Gates MRI & PAN-TB Consortium: Phase 2b/c TB treatment shortening trial.
Gates MRI selected SureAdhere as the central adherence platform for the PAN-TB TBDO6 study, evaluating two novel regimens across 11 sites in South Africa and the Philippines. Exceptionally high adherence allowed early go/no-go decisions without adherence as a confounding factor.
"Why can't we use SureAdhere in all of our clinical trials?"
Dermata Therapeutics: Protocol compliance for Phase 2 & 3 dermatology trials.
SureAdhere has partnered with Dermata Therapeutics since 2019, supporting two Phase 2 clinical trials evaluating DMT310 for acne and rosacea across 32 US sites. High adherence across both trials enabled confident futility decisions for rosacea and removed adherence as a confounder on primary endpoints for acne. Dermata's board subsequently selected SureAdhere for their Phase 3 acne trial, currently enrolling.
"The SureAdhere leadership team and their VDOT software have provided the confidence in treatment compliance we have been seeking for years in conducting clinical research. The application is very user friendly and available for all subjects randomized to our clinical studies."
Learn how we can support your trial requirements.
Whether you're planning a new trial or looking to improve adherence in an active study, our team is ready to walk you through the platform and discuss your specific requirements.